Suppr超能文献

脑外多巴胺拮抗剂多潘立酮可阻断溴隐亭对人体催乳素和促甲状腺激素分泌的抑制作用。

The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man.

作者信息

Svet-Moldavsky I, Svet-Moldavsky G, Zinzar S, Holland J, Vergara C, Arlin Z, Koziner B, Clarkson B

出版信息

Biomedicine. 1981 Oct;35(5):142-4.

PMID:6797487
Abstract

The effects of a single oral dose of 2.5 mg bromocriptine on serum level of TSH and prolactin were studied in a group of normal male subjects. Bromocriptine effectively inhibited basal TSH and prolactin concentration as well as the prolactin and TSH response to TRH given 4 hours later. The prior administration of the extracerebral dopamine antagonist domperidone reversed the endocrine effects of bromocriptine. The results suggest that dopamine receptors located at the pituitary may regulate TSH (and prolactin) release in man.

摘要

在一组正常男性受试者中研究了单次口服2.5毫克溴隐亭对血清促甲状腺激素(TSH)和催乳素水平的影响。溴隐亭有效抑制基础TSH和催乳素浓度,以及4小时后给予促甲状腺激素释放激素(TRH)时催乳素和TSH的反应。预先给予外周多巴胺拮抗剂多潘立酮可逆转溴隐亭的内分泌作用。结果表明,位于垂体的多巴胺受体可能调节人类TSH(和催乳素)的释放。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验